In agreement with these data, Jim et al. [33] detected nephrinuria using an enzyme-linked immunosorbent assay in 54% of type 2 diabetes subjects with NO, suggesting that urinary nephrin could be a potential pre-clinical biomarker of DN. Here, NPHS1 is linked to liver dysplastic nodule.